Results 181 to 190 of about 2,115,870 (306)
The DLST K409 succinylation mediated by CPT1A promotes OXPHOS and redox homeostasis through regulating enzyme activity, thereby promoting the malignant progression of LUAD. Notably, the succinylation of DLST can enhance the cuproptosis resistance by inhibiting its lipoylation.
Xuanxuan Li +9 more
wiley +1 more source
Association Between Oral Lichen Planus and Non-Oral Cancers: A Multicentre Case-Control SIPMO Study. [PDF]
Gioco G +62 more
europepmc +1 more source
Low-dose immunotherapy as a potentiator to increase the response with neo-adjuvant chemotherapy in oral cancers. [PDF]
Rathinasamy N, Muthu S, Krishnan A.
europepmc +1 more source
TNFRSF19 is an epigenetically silenced regulator of mitophagy in triple‐negative breast cancer. TNFRSF19 deficiency activates the TGFBR1–SMAD3–PINK1 axis to promote mitophagy and confer doxorubicin resistance, whereas decitabine‐mediated restoration of TNFRSF19 suppresses mitophagy and enhances doxorubicin sensitivity, revealing a targetable epigenetic–
Shiyang Liu +7 more
wiley +1 more source
MMP-9 as a diagnostic salivary biomarker for early detection of oral cancers: systematic review and meta-analysis. [PDF]
Shaukat A +4 more
europepmc +1 more source
Editorial: Frontiers in oral health: Highlights in oral cancers 2021/2. [PDF]
Kujan O, Coletta RD.
europepmc +1 more source
Mesenchymal GSCs preferentially uptake palmitic acid, thereby promoting ZDHHC12‐mediated LDHA palmitoylation. This modification enhances LDHA enzymatic activity, drives glycolytic reprogramming, and facilitates exosomal LDHA‐mediated TAM regulation.
Zijie Gao +20 more
wiley +1 more source
Biomarker Potential of Vimentin in Oral Cancers. [PDF]
Mogre S +6 more
europepmc +1 more source
This study reveals that during skeletal aging, bone marrow adipocyte‐derived sDPP4 primes STING signaling in macrophages. In combination with mitochondrial DNA, this signaling activates CD38 and depletes local NAD+/NMN, thereby impairing osteogenesis.
Zhichao Li +12 more
wiley +1 more source
The Possibility of Plasma Membrane Transporters as Drug Targets in Oral Cancers. [PDF]
Sogawa C, Shimada K, Nakano K.
europepmc +1 more source

